Crinetics Pharmaceuticals Inc Stock News

Crinetics Pharmaceuticals Inc (NASDAQ:CRNX) – Analysts at Piper Sandler issued their FY2024 earnings per share (EPS) estimates for Crinetics Pharmaceuticals in a research report issued on Monday, Ma

Crinetics Pharmaceuticals Inc (NASDAQ:CRNX) – Investment analysts at SVB Leerink increased their Q1 2020 EPS estimates for shares of Crinetics Pharmaceuticals in a research report issued to clients

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs March 12.) Masimo...

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on ChemoCentryx (CCXI), Crinetics Pharmaceuticals (CRNX) and

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on ChemoCentryx ( CCXI – Research Report ), Crinetics Pharmaceuticals ( CRNX – Research Report ) and T

Crinetics Pharmaceuticals Inc:

SAN DIEGO, March 09, 2020 -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), a clinical stage pharmaceutical company focused on the discovery, development and commercialization.

SAN DIEGO, March 09, 2020 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), a clinical stage pharmaceutical company focused on the...

The coronavirus induced sell-off has created a number of attractive buying opportunities.

Crinetics Pharmaceuticals, Inc. (CRNX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Crinetics Pharmaceuticals, Inc. (CRNX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Crinetics Pharmaceuticals (NASDAQ:CRNX) was downgraded by equities researchers at BidaskClub from a “buy” rating to a “hold” rating in a research report issued to clients and investors on Wedn

Fmr LLC increased its holdings in shares of Crinetics Pharmaceuticals Inc (NASDAQ:CRNX) by 0.2% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commissi

California Public Employees Retirement System bought a new position in Crinetics Pharmaceuticals Inc (NASDAQ:CRNX) in the 4th quarter, according to its most recent disclosure with the Securities & Exc

It's easy to match the overall market return by buying an index fund. Active investors aim to buy stocks that vastly...